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ABSTRACT 
 
Transcranial electrical stimulation motor-evoked potential (TES-MEP) has been 
widely used to monitor major motor pathways in cranial and spinal surgeries. However, 
the results of TES-MEP might be strongly influenced by anesthetic agents and muscle 
relaxants. To compensate for this effect, a technique using compound muscle action 
potentials of the abductor pollicis brevis (APB-CMAP) evoked by median nerve 
stimulation has recently been reported. In this article, we adopted the transcranial 
electrical stimulation motor-evoked potential of facial muscles (TES-FMEP) instead of 
APB-CMAP as a reference waveform for compensation. Intraoperative monitoring in 
spinal surgeries using TES-MEP, TES-FMEP and APB-CMAP was performed in 64 
patients. We compared with and without compensation methods using TES-FMEP and 
APB-CMAP to evaluate TES-MEP. The cases which demonstrated postoperative motor 
disturbance including transient symptoms were judged to be positive cases. Postoperative 
transient paraplegia was shown in one intramedullary tumor case among those 64 cases. 
Compensation by TES-FMEP exhibited the highest specificity (90.5%) and lowest false-
positive rate (9.5%) among the three compensation modalities when evaluated at 80% 
amplitude decrease. TES-FMEP, being derived from motor cortex stimulation, is not 
influenced by the original spinal lesion or surgical manipulation of the spine. Therefore, 
compensation using TES-FMEP is suitable for intraoperative monitoring during spinal 
surgery. The authors advocate TES-FMEP as a reference waveform for the compensation 
of intraoperative TES-MEP. 
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evoked potential 
 
 
INTRODUCTION 
 
Intraoperative neurophysiological monitoring has been widely performed to reduce 
morbidities such as motor paralysis in spinal surgery 6,8,16). Transcranial electrical 
stimulation motor-evoked potential (TES-MEP) is used to monitor major motor pathways 
14). Because the administration of muscle relaxants at the induction of general anesthesia 
strongly affects the waveform of TES-MEP, some kind of compensatory technique to 
exclude the effect of muscle relaxant is necessary 6,8,22). The use of the compound muscle 
action potential (CMAP) of the abductor pollicis brevis (APB) obtained by stimulation of 
the median nerve has been reported as a reference waveform of TES-MEP 21). However, 
the origins of TES-MEP are different from those of APB-CMAP: namely, TES-MEP is 
evoked by stimulation of the motor cortex, whereas APB-CMAP is evoked by stimulus 
of the peripheral nerves. Moreover, in patients with severe myelopathy causing 
amyotrophy of the upper extremities, axonal degeneration may make the waveform of 
APB-CMAP unstable, irrespective of the presence of muscle relaxants 15). In skull base 
surgeries such as those dealing with acoustic neurinoma and petroclival tumors, 
transcranial electrical stimulation motor-evoked potential of facial muscles (TES-FMEP) 
has already been used to monitor facial nerve function 1,9,10,12). As the entire TES-FMEP 
stimulus pathway is contained within the cranium, we can hypothesize that TES-FMEP 
is ideal in that no manipulation during spinal surgery can affect its pathway 17). In this 
article, we evaluate for the first time the validity of TES-FMEP as a reference waveform 
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in spinal surgery.  
 
METHODS 
 
From September 2009 to January 2015, TES-MEP, APB-CMAP and TES-FMEP 
monitoring were performed in 64 patients (45 men and 19 women), ranging from 25 to 
84 years of age (mean, 59.4 yr) who underwent spinal surgery for 41 cervical, 4 thoracic 
and 19 lumbar lesions. Patient disorders were varied, as indicated in Table 1. All 
monitoring was performed using the following system: Viking IV, Viking Select, and 
Endeavor CR (Nicolet Biomedical Inc., Madison, WI). The muscle relaxant was 
exclusively administered during anesthetic induction and tracheal intubation, and then 
total intravenous anesthesia was performed with remifentanil and propofol in all cases. 
Neuromuscular monitoring was performed by TOF (train-of-four) nerve stimulation. The 
needle electrodes were placed transcutaneously on the scalp according to the international 
10-20 electroencephalogram system 20). Transcranial electrical stimulation was 
accomplished through a pair of needle electrodes (Natus Neurology, Middleton, WI) fixed 
2 cm anterior to C3 and C4. Two surface electrodes (Natus Neurology, Middleton, WI) 
were routinely placed at orbicularis oris for recording TES-FMEP. The reference 
waveforms of TES-MEP, TES-FMEP and APB-CMAP were recorded after complete 
recovery of TOF response applied to the ulnar nerve. TES-MEP was obtained by 
supramaximal stimulation of a TOF stimuli with a 2-ms inter-stimulus interval (ISI). 
Target muscles of TES-MEP were bilateral abductor pollicis brevis and lower extremity 
muscles including flexor halluces brevis, anterior tibialis and gastrocnemius. Each TES-
MEP were simultaneously recorded. Selection of the target muscles of lower extremities 
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were judged necessity with each cases. In TES-FMEP, the ISI was modified to 1-ms 
because TES-FMEP has a shorter onset latency than TES-MEP. Recording surface 
electrodes were placed at APB and lower extremity muscles for TES-MEP. APB-CMAP 
was obtained after stimulation through the electrodes at the wrist: two surface electrodes 
were placed parallel to the nerve, with the cathode situated distally. Median nerve 
stimulation was performed by supramaximal stimulation within 50 mA maximum 
intensity of a single stimulus with 0.2 ms duration. To record APB-CMAP, same 
electrodes placed on the APB for TES-MEP were used. APB-CMAP and TES-FMEP 
were recorded within 5 seconds after recording of TES-MEP. Each waveforms were 
recorded at four point: at the beginning of operation, before and after decompression, and 
at the end of operation. At the beginning of operation, we confirmed full recovery of train 
of four ratio. The amplitude of TES-MEP was adjusted by two reference waves: fcMEP 
(facial-compensated MEP) = TES-MEP divided by TES-FMEP, and acMEP (APB-
compensated MEP) = TES-MEP divided by APB-CMAP. The fcMEP and acMEP were 
calculated immediately after eliciting each waveform during surgery. Amplitude 
reduction exceeding cut-off value at least one muscle on each extremities was judged a 
positive. Manual muscle test (MMT) was employed to evaluate postoperative motor 
weakness. Detection of at least 1 grade decrease on MMT was judged a positive. 
Postoperative motor function was evaluated immediately after surgery. The cases which 
demonstrated postoperative motor disturbance on MMT including transient symptoms 
were judged to be positive cases. To evaluate correlation between motor weakness and 
alteration of TES-MEP, we adopted the amplitudes of the beginning and end point of the 
operation. TES-MEP amplitudes easily fluctuate by various reason during operation, 
therefore, we ruled out value of before and after decompression. All data are expressed 
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as means ± SDs per group and were analyzed by Tukey's honestly significant difference 
(HSD) test using SPSS 16.0J for Windows (SPSS Inc., Chicago, IL). The false-positive 
rate (FPR) was calculated using the formula: FPR = 1 − specificity. Statistical significance 
was assessed using two-way repeated-measures ANOVA for the value of perioperative 
amplitude and onset latency. Student’s t-test was used to assess the change ratio of 
amplitude and onset latency after compensation. Statistical significance was determined 
as a p-value < 0.05. The protocol for the human study was approved by the Institutional 
Review Board of Hiroshima University. 
 
RESULTS 
 
TES-MEP during spine surgery was recorded from 300 muscles in 64 cases. TES-
MEP, TES-FMEP and APB-CMAP were recordable in all cases. No case was complicated 
with postoperative motor paralysis. Detailed waveform data of TES-FMEP and APB-
CMAP are summarized in Table 2. The change ratio of amplitude and onset latency of 
TES-FMEP and APB-CMAP between the beginning and end point of surgery had no 
significant change. The perioperative behavior of amplitude of TES-FMEP and APB-
CMAP showed no significant difference (Fig. 1). 
One intramedullary tumor case demonstrated postoperative transient paraplegia. 
Amplitudes of lower extremities were decreased during the dissection of the tumor bed 
from the spinal cord. The operation continued on the basis of fact that reduction in 
amplitude compensated by fcMEP were >50% but <80%. The neurological symptoms 
had resolved completely one week following tumor resection. When we set >50% 
reduction in amplitude as critical, the sensitivities of all methods were 100%, while the 
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specificities were as follows: TES-MEP, fcMEP, and acMEP were 68.3%, 61.9%, and 
61.9%, respectively. The false-positive rates were as follows: TES-MEP, fcMEP, and 
acMEP were 31.7%, 38.1%, and 38.1%, respectively. With cut-off value of >80% 
reduction in amplitude as critical, the sensitivities of all methods were 100% and the 
specificities were as follows: TES-MEP, fcMEP, and acMEP were 87.3%, 90.5% and 
84.1%, respectively. The false positive rates were as follows: TES-MEP, fcMEP, and 
acMEP were 12.7%, 9.5% and 15.9%, respectively (Table 3). These results indicate that 
a > 80% reduction in compensated amplitude should be a critical alarming line in our 
institute and under this regime, compensation by fcMEP can be regarded as the most 
reliable method. 
 
Case illustration 
A 69-year-old man presenting with intermittent claudication without motor weakness 
underwent laminectomy for L4-5 canal stenosis. During surgery, TES-MEP recorded in 
the right gastrocnemius muscle showed an 84% reduction in amplitude. With regard to 
the compensated data, fcMEP and acMEP were 60% and 75%, respectively. TES-MEPs 
from bilateral anterior tibialis and left gastrocnemius also demonstrated the same 
tendency. Because the reduction of the compensated amplitude was < 80%, we judged 
that the decrease in the amplitude was not critical and continued the operation. The patient 
did not demonstrate any motor weakness postoperatively (Fig. 2). 
 
DISCUSSION 
 
Intraoperative neurophysiological monitoring has been widely used to reduce 
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morbidity in spinal surgery 6,8). In particular, TES-MEP has become a standard monitoring 
tool after the introduction of total intravenous anesthesia with propofol and opioid agents 
4). The problem remains that anesthetic agents such as muscle relaxant may significantly 
affect the amplitude and latency of MEP 6,8,22). Although muscle relaxant is used 
exclusively at the induction of general anesthesia in our series, it is easy to speculate that 
a remnant relaxant may reduce the amplitude of MEP at the beginning of the operation. 
Thus, proper interpretation of the altering waveform requires some kind of compensatory 
technique. In particular, for those surgeries where continuous administration of a muscle 
relaxant must be used for some reason, a compensatory technique is required. Such a 
compensatory technique using APB-CMAP evoked by median nerve stimulation has 
recently been reported 21). Although APB-CMAP is technically easy, the origin of its 
evoked potential is significantly different from that of TES-MEP. APB-CMAP is derived 
from the stimulation of the peripheral nerve, whereas TES-MEP is evoked by stimulating 
the motor cortex. When myelopathy is severe enough to demonstrate amyotrophy of the 
upper extremities, axonal degeneration may make the waveform of APB-CMAP unstable, 
irrespective of the presence of muscle relaxant 15). Facial nerve motor endplate is resistant 
to muscle relaxant, however recovers more rapidly from nondepolarizing muscle relaxant 
2,3). In this study, all evoked potentials were obtained after complete recovery of TOF 
response, eliminating the effect of muscle relaxants. Moreover, anesthetic fade is 
mentioned as a factor influencing MEP amplitude. Administration of 
desflurane/N2O/narcotic or desflurane/propofol/narcotic suppress MEP dependent to 
duration under anesthesia 13). In this study, remifentanil and propofol without volatile 
agents were adopted for maintenance anesthesia. The suppressive effect of remifentanil 
on MEP under inducing surgical anesthesia was far less marked 18). Although effect of 
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anesthetic fade on TES-FMEP is unclear, we suppose that is negligible under our 
anesthesia for the above reason. A compensation technique using transcranially evoked 
CMAP from the sternocleidomastoideus muscle (TC-SCMMEP) as a reference waveform 
in spinal surgery has been reported 23). However, the nucleus of the accessory nerve is 
widely distributed from the medulla oblongata to the fifth or sixth segment of the cervical 
cord 19). Therefore, original cervical cord pathology or surgical manipulation of the 
cervical cord may influence the waveform of TC-SCMMEP. TES-FMEP, TES-MEP, and 
TC-SCMMEP are all derived from motor cortex stimulation. TES-FMEP has already 
been applied to monitor facial nerve function during surgery for skull base lesions such 
as acoustic schwannomas and petroclival meningiomas 1,10,12). Because the entire TES-
FMEP stimulation pathway is enclosed within the cranium, we can estimate that a 
reference wave obtained by TES-FMEP is not affected by any manipulation during spinal 
surgery. Since the origin is different, it is insignificant to compare the absolute value of 
amplitude and onset latency of TES-FMEP and APB-CMAP. We demonstrated that a 
comparison in the form of relative amplitude was useful in evaluating the intraoperative 
behavior of TES-MEP. Because there was no significant perioperative behavior in the 
amplitude of TES-FMEP and APB-CMAP, TES-FMEP can be used as a reference 
waveform for compensation that shows no inferiority to APB-CMAP. Therefore, we 
consider that TES-FMEP can be used as a reference waveform for compensation in place 
of APB-CMAP. 
In fact, in this study fcMEP demonstrated the highest value of specificity and the 
lowest false-positive rate when evaluated at an 80% amplitude reduction, compared with 
both TES-MEP and acMEP. It has been reported that the threshold for motor palsy in 
TES-MEP compensated by APB-CMAP was a > 80% reduction in the amplitude 21). In 
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the present study, the threshold of fcMEP for motor palsy was assumed to be the same as 
that of acMEP because the behavior of TES-FMEP showed the same tendency as APB-
CMAP. 
The question remains as to whether TES-FMEP obtained by our technique is truly 
derived from the motor cortex. The current spread running outside of the skull may 
directly stimulate the facial nucleus in the brainstem or facial nerve outside the cranium. 
To avoid current spread and stimulate the motor cortex effectively, we placed the tip of a 
needle electrode transcutaneously on the surface of the calvarium 11,24). Low-voltage 
stimulation under 400 mV exclusively excites the motor cortex and avoids motion 
artifacts of the trunk and extremities. Because the cranial nerves, including the facial 
nerve, are readily activated under general anesthesia, single-pulse stimulation does not 
induce a response. Thus, it is important to confirm that single-pulse stimulation at the 
same intensity as that used in TES-FMEP does not induce a response from the facial 
nucleus 9). Activation of the facial nucleus in the brainstem requires the temporal 
summation of a series of descending corticobulbar action potentials 5,7). In our study, TES-
FMEP was recorded with a mean onset latency of 11.4 ms. That is longer than 6.0 ms 
which is a latency of the direct stimulation of the facial nerve at the CP angle 6). If TES-
FMEP is recorded with an onset latency under 6 ms, it might be evoked from the 
brainstem stimulated by current spread. Therefore, TES-FMEP in our study is concluded 
to be of motor cortical origin. 
 Because of its short onset latency, recording of TES-FMEP is relatively difficult. 
When we chose an ISI of 2 ms, the waveform of TES-FMEP could be superscribed by a 
stimulation artifact. Thus, we modified ISI to 1 ms because such a short stimulatory 
duration prevents superscription 9). 
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We describe a novel technique of intraoperative compensation of TES-MEP using 
TES-FMEP in spinal surgery. In this article, fcMEP demonstrated more reliable results 
than the raw data of TES-MEP and acMEP. We conclude that compensation using TES-
FMEP is suitable for intraoperative monitoring during spinal surgery. Although 
accumulation of clinical data is mandatory, compensation of TES-MEP with TES-FMEP 
appears to be a good modality of choice in spinal surgery. 
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Figure legends 
 
Fig. 1. Perioperative amplitude behavior of APB-CMAP and TES-FMEP. 
Each waveforms were recorded at four point: at the beginning of operation, before and 
after decompression, and at the end of operation. A significant value for Mauchly’s test 
of sphericity indicates that the assumption of sphericity has been violated. We can report 
that when using an ANOVA with two-way repeated measures with a Greenhouse–Geisser 
correction, there are no interaction effects between the longitudinal evaluation of the 
amplitude of APB- and facial-CMAP. 
A, beginning of operation; B, before decompression; C, after decompression; D, end of 
operation. 
a, APB-CMAP; b, TES-FMEP 
 
Fig. 2. Amplitude change of target muscle and reference waveforms. 
Amplitudes of the lower extremities became small as the operation progressed. At the 
same time, the amplitude reduction of the reference waveforms was slight. For example, 
the muscle MEP of right gastrocnemius decreased to 16%; however, the amplitude 
compensated by TES-FMEP and APB-CMAP were 40% and 25% of the baseline value, 
respectively. 
 
Table 1. Distribution of object disorder and region 
Table 2. Comparison of reference waveform of amplitude, onset latency and relative value 
Table 3. False positive rate on amplitude of MEP 
